{
  "id": "5a67ab79b750ff445500000b",
  "type": "factoid",
  "question": "CURB65 score is used for stratification of which disease?",
  "ideal_answer": "CURB65 (confusion, urea, respiration, blood pressure; age>65\u2009years) is used for assessment of pneumonia severity.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26874956",
    "http://www.ncbi.nlm.nih.gov/pubmed/20920140",
    "http://www.ncbi.nlm.nih.gov/pubmed/26237261",
    "http://www.ncbi.nlm.nih.gov/pubmed/29161297",
    "http://www.ncbi.nlm.nih.gov/pubmed/21539743",
    "http://www.ncbi.nlm.nih.gov/pubmed/24931899",
    "http://www.ncbi.nlm.nih.gov/pubmed/28681972",
    "http://www.ncbi.nlm.nih.gov/pubmed/28678546",
    "http://www.ncbi.nlm.nih.gov/pubmed/16928720"
  ],
  "snippets": [
    {
      "text": "Severity assessment tools (e.g. CURB65) that are used to guide early management decisions in CAP have not been widely validated in low-income settings and locally adapted tools are required. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28681972",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Scores for the pneumonia severity index (PSI); CURB65 (confusion, urea, respiration, blood pressure; age>65\u2009years); Infectious Disease Society of America (IDSA) and American Thoracic Society (ATS) guidelines for severe CAP; Acute Physiology, Chronic Health Evaluation (APACHE) II; Sequential Organ Failure Assessment (SOFA); and quick SOFA (qSOFA) were calculated.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28678546",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29161297",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "AIM: (i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29161297",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: The present study confirms that assessment of MR-pro-ADM levels in CAP patients in addition to CURB scores increases the prognostic accuracy of CURB alone and may help rule out discrepancies arising from flawed clinical severity classification. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29161297",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The cytokine response during pneumonia is different in bacterial vs viral infections; some of these cytokines correlate with clinical severity scales such as CURB65 or SOFA. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874956",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The CURB65 score was developed to predict mortality risk in community acquired pneumonia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20920140",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16928720",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "CURB65 should not be supplanted by SIRS or SEWS for initial prognostic assessment in CAP.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16928720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The CURB65 score was developed to predict mortality risk in community acquired pneumonia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20920140",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We aimed to derive a practical algorithm combining the CURB65 score with ProADM-levels in patients with community-acquired pneumonia (CAP) and non-CAP-LRTI.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21539743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RESULTS CURB65 and ProADM predicted both adverse events and mortality similarly well in CAP and non-CAP-LRTI.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21539743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The combined CURB65-A risk score provided better prediction of death and adverse events than the CURB65 score in the entire cohort and in CAP and non-CAP-LRTI patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21539743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION Presepsin is a valuable biomarker in predicting severity and outcome in CAP patients in the ED and Presepsin in combination with CURB65 score significantly enhanced the predictive accuracy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931899",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND An intervention trial found a trend for shorter length of stay (LOS) in patients with community-acquired pneumonia (CAP) when the CURB65 score was combined with the prognostic biomarker proadrenomedullin (ProADM) (CURB65-A).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26237261",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A composite score (CURB65-A) was created combining CURB65 classes with ProADM cut-offs to further risk-stratify patients.<br><b>RESULTS</b>: CURB65 and ProADM predicted both adverse events and mortality similarly well in CAP and non-CAP-LRTI.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21539743",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D004194"
  ],
  "exact_answer": "pneumonia"
}